As of June 10, 2026, Biohaven's top three insider holders are Gregory Bailey (Director, 2.02Mn shares), Vlad Coric (Chief Executive Officer, 1.94Mn shares), Vlad Coric (Chief Executive Officer, 1.80Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Julia P Gregory | - | 25,665 | 0 | 26 Oct, 2022 |
| Robert J Hugin | - | 12,959 | 0 | 12 Oct, 2022 |
| Gregory Bailey | - | 2,020,071 | 0 | 17 Nov, 2025 |
| Michael Thomas Heffernan | - | 15,178 | 0 | 12 Oct, 2022 |
| Kimberly Gentile | Svp, Clinical Operations | 99,557 | 0 | 07 Jan, 2026 |
| Vlad Coric | Chief Executive Officer | 0 | 1,935,821 | 17 Nov, 2025 |
| Bruce Car | Chief Scientific Officer | 0 | 30,000 | 20 Jun, 2024 |
| Kishan Mehta | - | 5,320 | 17,342 | 19 Mar, 2026 |
| George C. Clark | Vp, Chief Accounting Officer | 66,978 | 0 | 07 Jan, 2026 |
| Matthew Buten | Chief Financial Officer | 195,652 | 0 | 07 Jan, 2026 |
| Irina Antonijevic | - | 2,535 | 0 | 29 Dec, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Mar, 2026 | Kishan Mehta | Common Shares | D | 17,342 | $0.00 | 5,320 | D | G |
| 17 Mar, 2026 | Kishan Mehta | Common Shares | D | 17,342 | $0.00 | 5,320 | D | G |
| 17 Mar, 2026 | Kishan Mehta | Common Shares | A | 17,342 | $0.00 | 17,342 | I | G |
| 17 Mar, 2026 | Kishan Mehta | Common Shares | A | 17,342 | $0.00 | 17,342 | I | G |
| 27 Feb, 2026 | Bruce Car | Stock Options (Right to buy) | A | 175,000 | $0.00 | 175,000 | D | A |
| 27 Feb, 2026 | Matthew Buten | Stock Options (Right to buy) | A | 175,000 | $0.00 | 175,000 | D | A |
| 27 Feb, 2026 | Matthew Buten | Stock Options (Right to buy) | A | 175,000 | $0.00 | 175,000 | D | A |
| 27 Feb, 2026 | George C. Clark | Stock Options (Right to buy) | A | 50,000 | $0.00 | 50,000 | D | A |
| 27 Feb, 2026 | Bruce Car | Stock Options (Right to buy) | A | 175,000 | $0.00 | 175,000 | D | A |
| 27 Feb, 2026 | Kimberly Gentile | Stock Options (Right to buy) | A | 175,000 | $0.00 | 175,000 | D | A |
| 27 Feb, 2026 | George C. Clark | Stock Options (Right to buy) | A | 50,000 | $0.00 | 50,000 | D | A |
| 27 Feb, 2026 | Kimberly Gentile | Stock Options (Right to buy) | A | 175,000 | $0.00 | 175,000 | D | A |
| 27 Feb, 2026 | Vlad Coric | Stock Options (Right to buy) | A | 550,000 | $0.00 | 550,000 | D | A |
| 05 Jan, 2026 | George C. Clark | Common Shares | A | 2,500 | $0.00 | 68,095 | D | M |
| 05 Jan, 2026 | Bruce Car | Common Shares | A | 4,750 | $0.00 | 10,096 | D | M |
| 05 Jan, 2026 | Vlad Coric | Common Shares | A | 14,250 | $0.00 | 1,811,398 | D | M |
| 05 Jan, 2026 | Matthew Buten | Common Shares | A | 4,250 | $0.00 | 198,246 | D | M |
| 05 Jan, 2026 | Kimberly Gentile | Common Shares | A | 3,750 | $0.00 | 101,513 | D | M |
| 05 Jan, 2026 | Kimberly Gentile | Common Shares | A | 3,750 | $0.00 | 101,513 | D | M |
| 05 Jan, 2026 | Bruce Car | Common Shares | A | 4,750 | $0.00 | 10,096 | D | M |